ATYR peer analysis
ATYR (ATYR) against its competitors: price, today's move, 1-year return and market value side by side.
- ATYR's peers: ACRV (Acrivon Therapeutics), ALXO (ALX Oncology), CAMP (CAMP4 Therapeutics), DTIL (Precision BioSciences), HYFT (MindWalk), MGX (Metagenomi Therapeutics), RLMD (Relmada Therapeutics), UNCY (Unicycive Therapeutics).
ATYR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRV Acrivon Therapeutics | $1.40 | -10.26% | -40.68% | $60.08M |
| ALXO ALX Oncology | $1.06 | 3.92% | -27.89% | $137.03M |
| CAMP CAMP4 Therapeutics | $4.00 | -2.44% | 7.82% | $251.02M |
| DTIL Precision BioSciences | $7.40 | 7.09% | 53.53% | $206.72M |
| HYFT MindWalk | $0.80 | -11.30% | -55.90% | $37.98M |
| MGX Metagenomi Therapeutics | $0.61 | -2.85% | -61.88% | $23.21M |
| RLMD Relmada Therapeutics | $2.62 | -15.76% | -37.32% | $279.53M |
| UNCY Unicycive Therapeutics | $3.41 | -3.40% | -38.34% | $99.52M |
| ATYR aTyr Pharma | $3.69 | -9.56% | 446.50% | $9.05M |